Fri, March 31, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Edward White Reiterated (TGTX) at Strong Buy and Held Target at $24 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Doug Becker Maintained (TH) at Buy with Decreased Target to $20 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Manav Patnaik Maintained (TRU) at Hold with Decreased Target to $67 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Jason Butler Reiterated (TRVN) at Buy and Held Target at $50 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Douglas Tsao Reiterated (TRVN) at Strong Buy with Decreased Target to $225 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Jimmy Bhullar Maintained (TRV) at Sell with Increased Target to $185 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Elemer Piros Reiterated (UNCY) at Strong Buy and Held Target at $24 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Kristina Ruggeri Maintained (ULTA) at Strong Buy with Increased Target to $600 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Anthony Vendetti Maintained (UGRO) at Strong Buy with Decreased Target to $7 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Josh Baer Maintained (UDMY) at Hold with Decreased Target to $14 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Mason Carrico Initiated (TXG) at Buy and Held Target at $65 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Ed Arce Reiterated (AKBA) at Hold and Held Target at $1.25 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Jonathan Wolleben Reiterated (ALT) at Buy and Held Target at $15 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Eliana Merle Maintained (BNTX) at Hold with Decreased Target to $153 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Jeffrey Osborne Maintained (BOC) at Buy with Increased Target to $42 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Patrick Walravens Reiterated (BRZE) at Buy and Held Target at $46 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Scott Berg Reiterated (BRZE) at Strong Buy and Held Target at $50 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Brian Schwartz Maintained (BRZE) at Buy with Increased Target to $36 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Brent Bracelin Maintained (BRZE) at Buy with Increased Target to $40 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Ronald Josey Maintained (BXP) at Hold with Decreased Target to $52 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Matthew Taylor Maintained (SYK) at Strong Buy with Increased Target to $320 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Donald Fandetti Maintained (SYF) at Hold with Decreased Target to $31 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Edward Reilly Reiterated (SWAG) at Strong Buy and Held Target at $4.5 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Gerald Pascarelli Reiterated (STZ) at Buy and Held Target at $255 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Lauren Lieberman Maintained (STZ) at Buy with Increased Target to $279 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Anthony Hau Maintained (SUI) at Strong Buy with Decreased Target to $163 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
David Nierengarten Reiterated (STRO) at Buy and Held Target at $20 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Andrew Fein Maintained (STRO) at Strong Buy with Decreased Target to $16 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Peter Grom Maintained (SPB) at Strong Buy with Increased Target to $87 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Cody Acree Reiterated (SMTC) at Strong Buy and Held Target at $45 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Craig Ellis Maintained (SMTC) at Buy with Decreased Target to $40 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Cody Ross Maintained (SMPL) at Strong Buy with Increased Target to $45 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
John Freeman Maintained (SM) at Buy with Decreased Target to $38 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Daniel Chan Upgraded (BB) to Hold and Held Target at $4 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Jason McCarthy Maintained (BCLI) at Strong Buy with Increased Target to $150 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Seth Sigman Upgraded (AAP) to Hold and Decreased Target to $129 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Brian Cheng Maintained (ZYME) at Hold with Increased Target to $9 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Matthew Taylor Upgraded (ZBH) to Hold and Increased Target to $130 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Jimmy Bhullar Maintained (ACGL) at Hold with Increased Target to $62 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Andrew Bond Reiterated (BKKT) at Strong Buy and Held Target at $53 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Elemer Piros Reiterated (ATAI) at Strong Buy and Held Target at $15 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Bill Sutherland Reiterated (AUGX) at Strong Buy and Held Target at $5 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Raghuram Selvaraju Maintained (AVXL) at Strong Buy with Increased Target to $54 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Judah Frommer Maintained (CADL) at Buy with Decreased Target to $7 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Cody Ross Maintained (CAG) at Strong Buy with Decreased Target to $43 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Daniel Grosslight Initiated (CAH) at Hold and Held Target at $77 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Subash Chandra Maintained (AR) at Strong Buy with Decreased Target to $36 on, Mar 31st, 2023
[ Fri, Mar 31st 2023 ]: WOPRAI
Graig Suvannavejh Initiated (VIGL) at Strong Buy and Held Target at $15 on, Mar 31st, 2023

David Nierengarten Reiterated (STRO) at Buy and Held Target at $20 on, Mar 31st, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-mar-31st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
David Nierengarten of Wedbush, Reiterated "Sutro Biopharma, Inc." (STRO) at Buy and Held Target at $20 on, Mar 31st, 2023.

David has made no other calls on STRO in the last 4 months.



There are 2 other peers that have a rating on STRO. Out of the 2 peers that are also analyzing STRO, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David

  • Asthika Goonewardene of "Truist Securities" Maintained at Strong Buy with Increased Target to $25 on, Friday, January 13th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $18 on, Tuesday, January 10th, 2023